Growth Metrics

Innoviva (INVA) Common Equity: 2010-2025

Historic Common Equity for Innoviva (INVA) over the last 14 years, with Sep 2025 value amounting to $1.0 billion.

  • Innoviva's Common Equity rose 51.07% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 51.07%. This contributed to the annual value of $691.2 million for FY2024, which is 2.40% up from last year.
  • Per Innoviva's latest filing, its Common Equity stood at $1.0 billion for Q3 2025, which was up 41.29% from $714.8 million recorded in Q2 2025.
  • Innoviva's 5-year Common Equity high stood at $1.0 billion for Q3 2025, and its period low was $393.7 million during Q2 2021.
  • For the 3-year period, Innoviva's Common Equity averaged around $683.6 million, with its median value being $668.5 million (2024).
  • Data for Innoviva's Common Equity shows a peak YoY increase of 71.65% (in 2021) and a maximum YoY decrease of 20.10% (in 2021) over the last 5 years.
  • Innoviva's Common Equity (Quarterly) stood at $525.9 million in 2021, then grew by 7.58% to $565.8 million in 2022, then rose by 19.29% to $675.0 million in 2023, then grew by 2.40% to $691.2 million in 2024, then surged by 51.07% to $1.0 billion in 2025.
  • Its Common Equity was $1.0 billion in Q3 2025, compared to $714.8 million in Q2 2025 and $646.9 million in Q1 2025.